168
Participants
Start Date
June 28, 2018
Primary Completion Date
April 8, 2019
Study Completion Date
April 8, 2019
t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
Participants will use the Tandem t:slim X2 with Control-IQ Technology \& Dexcom G6 CGM for 6 months at home.
Sensor-augmented pump (SAP)
Participants will use an insulin pump with no automated insulin delivery and a study CGM (Dexcom G6) for 6 months at home. Pump-users at the time of enrollment will use their personal pump in this arm. Multiple daily injection (MDI) users at the time of enrollment will use a t:slim X2 insulin pump without Control-IQ technology.
Icahn School of Medicine at Mount Sinai, New York
University of Virginia Center for Diabetes Technology, Charlottesville
Mayo Clinic, Rochester
Barbara Davis Center, University of Colorado, Aurora
Sansum Diabetes Research Institute, Santa Barbara
Stanford University, Stanford
Harvard University (Joslin Diabetes Center), Boston
Collaborators (1)
Jaeb Center for Health Research
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Tandem Diabetes Care, Inc.
INDUSTRY
DexCom, Inc.
INDUSTRY
Roche Diagnostics GmbH
INDUSTRY
University of Virginia
OTHER